EATG » Tuberculosis

Tuberculosis

Global Fund, 3 private sector companies announce partnership agreements to improve global health, end HIV, TB, malaria Epidemics

Global Fund to Fight AIDS, Tuberculosis and Malaria’s “Voices”: From Davos, the Power of Public-Private Partnerships Christoph Benn, director of external relations at the Global Fund, discusses the role of public-private…

Survival outcomes improved with concurrent treatment for multidrug-resistant TB and HIV

Treatment of multidrug-resistant tuberculosis (TB) has comparable efficacy and survival rates in patients infected with HIV and not uninfected with HIV when patients with HIV are given antiretroviral therapy, according…

Aidspan publishes new issue of ‘Global Fund Observer’

Aidspan: Global Fund Observer Aidspan, an independent watchdog of the Global Fund to Fight AIDS, Tuberculosis and Malaria, published Issue 329 of the “Global Fund Observer.” The newsletter includes articles…

WHO leadership meets with TB civil society to strengthen engagement in accelerating the End TB response

17 January 2018 | Geneva: Civil society representatives met with WHO leadership in Geneva, on 15-16 January 2018, with the aim of strengthening collaboration to end TB. WHO Director-General Dr Tedros…

Fresh approach to TB vaccine offers better protection

New vaccine completely protected 41 percent of nonhuman primates; standard vaccine protected none A unique platform that resulted in a promising HIV vaccine has also led to a new, highly…

WHO position statement on the use of delamanid for MDR-TB

15 January 2018 | Geneva: The World Health Organization (WHO) Global Tuberculosis Programme has released a Position Statement on the use of delamanid in treatment of multidrug-resistant tuberculosis (MDR-TB), following…

TB Europe Coalition releases two new publications

TB Europe Coalition released two new publications - an information brochure about the forthcoming United Nations High-Level Meeting on TB to be held in September this year, and a set…

Investigation questions transparency for failed TB vaccine

The BMJ inquiry finds that researchers presented only select results from animal experiments when applying for funding and approval for human trials. Oxford University scientists developing the MVA85A vaccine, intended…

Positive LAM results predict mortality in children with HIV

Children with HIV in Kenya whose urine samples tested positive for lipoarabinomannan, or LAM — a biomarker of tuberculosis — had a nearly fivefold increased risk for mortality compared with…

An inside look at Ukraine’s terrifying TB outbreak

Strains of drug-resistant tuberculosis are spreading across Ukraine, where armed conflict and market misgivings are making a bad situation even worse. KRAMATORSK, 3 January 2018 — My car turns off…